Die gefählichste aller Religionen…
Re-giert sein heißt : Du bist ein Steuersklave!
Re-giert sein heißt : Du bist ein Steuersklave!
Arizona: Das erste FEMA – Camp ist „eröffnet
In einem neuen aufwendigen Video erklärt der IS seinen Gegnern den totalen Krieg. Dieser soll 2016 beginnen. in dem Propagandastreifen der Jihadisten wird eine Drohung gegen insgesamt 60 Länder der Welt ausgesprochen – darunter auch Deutschland.
Der ISIS droht in einem neuen, aufwendig hergestellten Video dem Westen, Russland und dem Iran mit den totalen Krieg. In dem rund vierminütigen, englischsprachigen Video wird einer „Koalition der Teufel“ gedroht, der 60 Länder angehören würden. Dann werden sämtliche Flaggen dieser Länder gezeigt, darunter auch Deutschland. Diese Länder würden gemeinsam mit der Türkei, dem Iran und Russland gegen das Kalifat kämpfen.
Diese „Koalition des Teufels“ werde laut Video demnächst noch auf 80 Länder anwachsen. Dann werde es zum ultimativen Endkampf gegen die „Ungläubigen“ kommen. Dieser totale Krieg soll 2016 geführt werden. Im Hintergrund zeigt das Video dazu eine riesige Feuersbrunst und einige Gräueltaten, die offensichtlich Angst einflößen sollen.
„Die Feinde des Islam werden zerstört in den Flammen des Krieges“ – droht verheißungsvoll eine Stimme im Hintergrund im Hollywood-Stil.
Der Streifen wirkt wie ein Trailer zu einem brutalen Horrorfilm, ist aber offenbar bitter ernst gemeint. Man habe die Symbole von Palmyra zerstört und jetzt werde man die Nationen auflösen, um – wie von Allah befohlen – die Scharia einzuführen.
Die zentrale Drohung der Miliz gilt jedoch primär den USA. Diese seien „angeblich die stärkste Armee der Geschichte“, dennoch aber stark demoralisiert. 6500 Soldaten würden jedes Jahr in den USA Selbstmord begehen. Amerika sei zu schwach, um Bodentruppen zu schicken („too weak to put boots on the ground“).
Das Territorium der IS sei jetzt schon größer als das von Großbritannien und acht mal größer als Belgien. Schließlich droht die Miliz mit neuen Anschlägen in den USA. Bereits in früheren Videos wurden dabei explizit Washington und New York genannt.
Das Video ist perfekt inszeniert und laut Experten von Profis produziert. Es dient offensichtlich der Propaganda besonders in Hinblick auf die muslimische Community. Diese könnten sich den Droh-Streifen bequem auf ihr Smartphone laden. Auf diese Weise wolle der IS Sympathisanten und rneue Mitkämpfer rekrutieren.
gefunden bei : http://brd-schwindel.org/isis-erklaert-den-totalen-krieg/
Original : von MMnews
Offener Brief von Professor Cees Hamelink: “Entschuldigung Herr Putin!”
Von Mar Kus – Am 04. Aug. 2014 – unter Politik32 Kommentare
von Andy Martin
Sehr geehrter Herr Präsident Putin,
hiermit möchten wir uns im Namen eines Teils niederländischer Bürger für unsere Regierung und unsere Medien entschuldigen.
Die Wahrheit wird verdreht um Sie und Ihr Land in ein schlechtes Licht zu rücken.
Machtlos müssen wir zusehen wie der Westen, unter der Führung der Vereinigten Staaten, Russland der Aktivitäten beschuldigt an denen sie selber beteiligt sind. Das planmäßige Messen mit zweierlei Maß ist verwerflich. Der Westen verurteilt ohne genügend Beweise zu erbringen. Wie Sie, ohne Beweise, verurteilt werden für das Verüben von sogenannten Verbrechen, ist eine äußerst freche und anstößige Angelegenheit.
Sie haben uns, während des Syrien-Konflikts, vor einem Weltkrieg gerettet. Der Gasangriff auf syrische Bürger wurde Assad in die Schuhe geschoben, obwohl Al- Qaida-ähnliche-Typen, trainiert und bewaffnet von den Vereinigten Staaten und bezahlt von Saudi-Arabien, diesen Massenmord auf ihrem Gewissen haben. Hiermit hoffte der Westen, dass die Welt sich gegen Assad wenden und ein Angriff auf das Land gutheißen würde.
Nicht lange danach haben westliche Organisationen die Opposition der ukrainischen Regierung aufgebaut, bewaffnet und trainiert um die Regierung zu stürzen. Die neuen Machthaber wurden durch den Westen in Windeseile anerkannt. Dieser neuen Regierung wurde von unserem Steuergeld Kredite als Belohnung vergeben, um sie damit zu verpflichten.
Die Bevölkerung der Krim war damit nicht einverstanden und zeigte das mittels friedlicher Demonstrationen. Gewalt, angewendet von anonymen Heckenschützen und später durch die ukrainische Armee hat dazu geführt, dass die Bewohner der Krim sich von der Ukraine trennen wollten. Ob Sie nun die Separatisten unterstützt haben oder nicht, es steht unserer Regierung nicht zu, Ihnen deshalb Vorwürfe zu machen.
Russland wird zu Unrecht, ohne Untersuchung und lückenlose Beweise, der Lieferung eines Waffensystems beschuldigt, das womöglich ein Passagierflugzeug abgeschossen hat. Aus oben genannten Gründen meint unsere Regierung Russland mit Sanktionen zu belegen.
Wir wache Niederländer, die diese Propaganda der westlichen Medien und die Lügen unserer Politiker durchschauen und ablehnen, wollen uns hiermit bei Ihnen entschuldigen. Es ist leider so, dass unsere Medien jede Art gesunder und unabhängiger Kritik verloren haben, und nur berichten was die Politik vorschreibt.
Dadurch haben die Bürger des Westens ernsthafte Probleme die Wahrheit zu erkennen, und versäumen so die Möglichkeit ihren Politikern bei den Wahlen einen Denkzettel zu verpassen.
Sehr geehrter Herr Präsident Putin, wir hoffen auf Ihre Weisheit. Wir wollen Frieden. Wir sehen, dass die westliche Politik gegen ihre Bürger und für einen Plan für eine Neue Weltordnung arbeitet. Das Vernichten von souveränen Staaten und das Töten von unzähligen Millionen Menschen ist für unsere westlichen Weltführer anscheinend das Opfer das dargebracht werden muss, um ihr Ziel zu erreichen. Wir, die Bürger der Niederlande wollen Gerechtigkeit und Frieden, auch mit Russland.
Wir wollen Ihnen hiermit deutlich machen, dass die niederländische Regierung nur für sich spricht. Wir hoffen mit dieser Erklärung unseren Anteil beitragen zu können, um die steigende Spannung zwischen unseren Staaten zu entschärfen.
D A N K E Herr Professor Hamelink!
DE Brief an Putin: http://ommekeer-nederland.nl/documents/brief-putin-de.pdf
EN Letter to Putin: http://ommekeer-nederland.nl/documents/letter-putin-en.pdf
NL Brief aan Putin: http://ommekeer-nederland.nl/documents/brief-aan-putin-nl.pdf
Professor Cees Hamelink. Waarom moet je niet geloven wat in de krant staat? http://youtu.be/_tf1FA3gqWE
Historische claim laat zien waarom de Krim Rusland aangaat http://bit.ly/1jN3m2x
Unabhängigkeit muss man sich leisten können. Wir brauchen deine Unterstützung!
gefunden bei: http://kosmische-tagesschau.de
Compositions and methods including and related to the Ebola Bundibugyo virus (EboBun) are provided. Compositions are provided that are operable as immunogens to elicit and immune response or protection from EboBun challenge in a subject such as a primate. Inventive methods are directed to detection and treatment of EboBun infection.
This application claims priority benefit of U.S. Provisional Application 61/108,175 filed 24 Oct. 2008; the contents of which are hereby incorporated by reference.
The invention provides the isolated human Ebola (hEbola) viruses denoted as Bundibugyo (EboBun) deposited with the Centers for Disease Control and Prevention (“CDC”; Atlanta, Ga., United States of America) on Nov. 26, 2007 and accorded an accession number 200706291. This deposit was not made to an International Depository Authority (IDA) as established under the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure, and is a non-Budapest treaty deposit. The deposited organism is not acceptable by American Type Culture Collection (ATCC), Manassas, Va., an International Depository Authority (IDA) as established under the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure. Samples of the stated Deposit Accession No. 200706291 will be made available to approved facilities for thirty years from the date of deposit, and for the lifetime of the patent issuing from, or claiming priority to this application.
FIELD OF THE INVENTION
The invention is related to compositions and methods directed to a novel species of human Ebola (hEbola) virus.
BACKGROUND OF THE INVENTION
The family Filoviridae consists of two genera, Marburgvirus and Ebolavirus, which have likely evolved from a common ancestor1. The genus Ebolavirus includes four species: Zaire, Sudan, Reston and Côte d’Ivoire (Ivory Coast) ebolaviruses, which have, with the exception of Reston and Côte d’Ivoire ebolaviruses, been associated with large hemorrhagic fever (HF) outbreaks in Africa with high case fatality (53-90%)2.
Viruses of each species have genomes that are at least 30-40% divergent from one another, a level of diversity that presumably reflects differences in the ecological niche they occupy and in their evolutionary history. Identification of the natural reservoir of ebolaviruses remains somewhat elusive, although recent PCR and antibody data suggest that three species of arboreal fruit bats may be carriers of Zaire ebolavirus3. No data has yet been published to suggest reservoirs for the Sudan, Reston and Côte d’Ivoire ebolavirus species. However, a cave-dwelling fruit bat has been recently implicated as a natural host for marburgvirus4, 5, supporting the hypothesis that different bat species may be the reservoir hosts for the various filoviruses.
Filovirus outbreaks are sporadic, sometimes interspersed by years or even decades of no apparent disease activity. The last new species of ebolavirus was discovered 14 years ago (1994), in Cote d’Ivoire (Ivory Coast), and involved a single non-fatal case, a veterinarian who performed an autopsy on an infected chimpanzee found in the Tai Forest6. No further disease reports have been associated with Côte d’Ivoire ebolavirus, in contrast to Zaire and Sudan ebolaviruses which have each caused multiple large outbreaks over the same time period.
In late November 2007, HF cases were reported in the townships of Bundibugyo and Kikyo in Bundibugyo District, Western Uganda. The outbreak continued through January 2008, and resulted in approximately 149 cases and 37 deaths2. Laboratory investigation of the initial 29 suspect-case blood specimens by classic methods (antigen capture, IgM and IgG ELISA) and a recently developed random-primed pyrosequencing approach identified this to be an Ebola HF outbreak associated with a new discovered ebolavirus species. These specimens were negative when initially tested with highly sensitive real-time RT-PCR assays specific for all known Zaire and Sudan ebolaviruses and Marburg viruses. This new species is referred to herein as “the Bundibugyo species”, abbreviated “EboBun”.
Accordingly, compositions and methods directed to the new Ebola virus species are described herein and the most closely related Ebola Ivory Coast species, which compositions and methods are useful for diagnosis and prevention of human Ebola virus infection; including related vaccine development, and prevention of hemorrhagic fever in a human population.
SUMMARY OF THE INVENTION
The present invention is based upon the isolation and identification of a new human Ebola virus species, EboBun. EboBun was isolated from the patients suffering from hemorrhagic fever in a recent outbreak in Uganda. The isolated virus is a member of the Filoviridae family, a family of negative sense RNA viruses. Accordingly, the invention relates to the isolated EboBun virus that morphologically and phylogenetically relates to known members filoviridae.
In one aspect, the invention provides the isolated EboBun virus deposited with the Centers for Disease Control and Prevention (“CDC”; Atlanta, Ga., United States of America) on Nov. 26, 2007 and accorded an accession number 200706291, as stated in the paragraph entitled “DEPOSIT STATEMENT” supra.
In another aspect, the invention provides an isolated hEbola EboBun virus comprising a nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of: a) a nucleotide sequence set forth in SEQ ID NO: 1; b) a nucleotide sequence that hybridizes to the sequence set forth in SEQ ID NO: 1 under stringent conditions; and c) a nucleotide sequence that has at least 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% identity to the SEQ ID NO: 1. In another aspect, the invention provides the complete genomic sequence of the hEbola virus EboBun.
In a related aspect, the invention provides nucleic acid molecules isolated from EboBun, or fragments thereof.
In another aspect, the invention provides proteins or polypeptides that are isolated from the EboBun, including viral proteins isolated from cells infected with the virus but not present in comparable uninfected cells; or fragments thereof. In one embodiment of the present invention, the amino acid sequences of the proteins or polypeptides are set forth in SEQ ID NOS: 2-9 and 59, or fragments thereof.
In a related aspect, the invention provides an isolated polypeptide encoded by the nucleic acid molecule of the inventive hEbola EboIC (Sequence ID No. 10) virus described above.
In another aspect, the invention provides an isolated hEbola EboIC virus comprising a nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of: a) a nucleotide sequence set forth in SEQ ID NO: 10; b) a nucleotide sequence that hybridizes to the sequence set forth in SEQ ID NO: 10 under stringent conditions; and c) a nucleotide sequence that has at least 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% identity to the SEQ ID NO: 10. In another aspect, the invention provides the complete genomic sequence of the hEbola virus EboIC.
In a related aspect, the invention provides nucleic acid molecules isolated from EboIC, or fragments thereof.
In another aspect, the invention provides proteins or polypeptides that are isolated from the EboIC, including viral proteins isolated from cells infected with the virus but not present in comparable uninfected cells; or fragments thereof. In one embodiment of the present invention, the amino acid sequences of the proteins or polypeptides are set forth in SEQ ID NOs: 11-19, or fragments thereof.
In a related aspect, the invention provides an isolated polypeptide encoded by the nucleic acid molecule of the inventive hEbola EboIC virus described above.
In other aspects, the invention relates to the use of the isolated hEbola virus for diagnostic and therapeutic methods based on EbBun, EboIC, or a combination thereof. In one embodiment, the invention provides a method of detecting in a biological sample an antibody immunospecific for the genus of West Afrin Ebola Species constituting hEbola EbBun and EboIC virus using at least one the inventive isolated hEbola virus described herein, or any of the inventive proteins or polypeptides as described herein. In another specific embodiment, the invention provides a method of screening for an antibody which immunospecifically binds and neutralizes hEbola EboBun. Such an antibody is useful for a passive immunization or immunotherapy of a subject infected with hEbola.
In another aspect, the invention provides an isolated antibody or an antigen-binding fragment thereof which immunospecifically binds to the hEbola virus of the invention described above.
In other aspects, the invention provides methods for detecting the presence, activity or expression of the Glade of Bundibungyo-Ivory Coast hEbola virus in a biological material, such as cells, blood, saliva, urine, feces and so forth; and specifically at least one of EbBun or EboIC.
In a related aspect, the invention provides a method for detecting the presence of the inventive hEbola virus described above in a biological sample, the method includes (a) contacting the sample with an agent that selectively binds to a West African hEbola virus; and (b) detecting whether the compound binds to the West African hEbola virus in the sample.
In another aspect, the invention provides a method for detecting the presence of the inventive polypeptide described above, in a biological sample, said method includes (a) contacting the biological sample with an agent that selectively binds to the polypeptide; and (b) detecting whether the agent binds to the polypeptide in the sample. In another aspect, the invention provides a method for detecting the presence of a first nucleic acid molecule derived from the inventive hEbola virus described above in a biological sample, the method comprising: (a) contacting the biological sample with an agent that selectively binds to the polypeptide; and (b) detecting whether the agent binds to the polypeptide in the sample.
In another aspect, the invention provides a method for propagating the hEbola virus in host cells comprising infecting the host cells with the inventive isolated hEbola virus described above, culturing the host cells to allow the virus to multiply, and harvesting the resulting virions. Also provided by the present invention are host cells infected with the inventive hEbola virus described above.
In another aspect, the invention provides a method of detecting in a biological sample the presence of an antibody that immunospecifically binds hEbola virus, the method comprising: (a) contacting the biological sample with the inventive host cell host described above; and (b) detecting the antibody bound to the cell.
In another aspect, the invention provides vaccine preparations, comprising the inventive hEbola virus, including recombinant and chimeric forms of the virus, nucleic acid molecules comprised by the virus, or protein subunits of the virus. The invention also provides a vaccine formulation comprising a therapeutically or prophylactically effective amount of the inventive hEbola virus described above, and a pharmaceutically acceptable carrier. In one embodiment, the invention provides a vaccine formulation comprising a therapeutically or prophylactically effective amount of a protein extract of the inventive hEbola virus described above, or a subunit thereof; and a pharmaceutically acceptable carrier. In another, the invention provides a vaccine formulation comprising a therapeutically or prophylactically effective amount of a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO: 1 or a complement thereof, and a pharmaceutically acceptable carrier. In another, the invention provides a vaccine formulation comprising a therapeutically or prophylactically effective amount of a nucleic acid molecule comprising any of inventive the nucleotide sequences as described above, or a complement thereof, and a pharmaceutically acceptable carrier.
In a related aspect, the invention provides an immunogenic formulation comprising an immunogenically effective amount of the inventive hEbola virus described above, and a pharmaceutically acceptable carrier. In another related aspect, the invention provides an immunogenic formulation comprising an immunogenically effective amount of a protein extract of the inventive hEbola virus described above or a subunit thereof, and a pharmaceutically acceptable carrier. In another related aspect, the invention provides an immunogenic formulation comprising an immunogenically effective amount of a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO: 1 or a complement thereof, and a pharmaceutically acceptable carrier. In another related aspect, the invention provides an immunogenic formulation comprising an immunogenically effective amount of a nucleic acid molecule comprising the inventive nucleotide sequence as described above or a complement thereof, and a pharmaceutically acceptable carrier. In another related aspect, the invention provides an immunogenic formulation comprising an immunogenically effective amount of any of the inventive polypeptides described above.
In another aspect, the present invention provides pharmaceutical compositions comprising antiviral agents of the present invention and a pharmaceutically acceptable carrier. In a specific embodiment, the antiviral agent of the invention is an antibody that immunospecifically binds hEbola virus or any hEbola epitope. In another specific embodiment, the antiviral agent is a polypeptide or protein of the present invention or nucleic acid molecule of the invention.
In a related aspect, the invention provides a pharmaceutical composition comprising a prophylactically or therapeutically effective amount of an anti-hEbola EboBun agent and a pharmaceutically acceptable carrier.
The invention also provides kits containing compositions and formulations of the present invention. Thus, in another aspect, the invention provides a kit comprising a container containing the inventive immunogenic formulation described above. In another aspect, the invention provides a kit comprising a container containing the inventive vaccine formulation described above. In another, the invention provides a kit comprising a container containing the inventive pharmaceutical composition described above. In another, the invention provides a kit comprising a container containing the inventive vaccine formulation described above. In another, the invention provides a method for identifying a subject infected with the inventive hEbola virus described above, comprising: (a) obtaining total RNA from a biological sample obtained from the subject; (b) reverse transcribing the total RNA to obtain cDNA; and (c) amplifying the cDNA using a set of primers derived from a nucleotide sequence of the inventive hEbola virus described above.
The invention further relates to the use of the sequence information of the isolated virus for diagnostic and therapeutic methods.
In another aspect, the present invention provides methods for screening antiviral agents that inhibit the infectivity or replication of hEbola virus or variants thereof.
The invention further provides methods of preparing recombinant or chimeric forms of hEbola
gefunden bei: http://www.avianflutalk.com/us-patent-20120251502-ebola-patent_topic31500.html
gefunden bei : http://rsvdr.wordpress.com
Veröffentlicht am 5. August 2014
Breedlove befürwortet einen Aufbau von NATO-Kräften in Europa, insbesondere Osteuropa. Die Allianz hat bereits ihre Präsenz in der Ostsee und dem Schwarzen Meer gestärkt und entsendete zusätzliche Militärflugzeuge nach Osteuropa.
Harald Kautz-Vella: MH17 is a covert bioweapon attack!
25. Juli 2014 Uns erreicht soeben eine Mail von Harald Kautz-Vella mit der Bitte um sofortige Veröffentlichung und dem Vermerk „Eilt!“. Wir hatten keine Zeit, den Artikel zu übersetzen. Wir stellen ihn nun im Original so ein, wie wir ihn erhalten haben. Es möge sich jeder bitte selbst ein Bild machen.
+++ Alert!!! Spanish flu outbreak imminent +++
+++ development of new medication against the virus accomplished and to be released within the next days +++
+++ Quarantine and UV disinfection of the ground immediately to be done +++
+++ Vaccine campaign might be second covert action to spread the virus, just as tested in 2009 in the Ukraine, also with Spanish flu, when after an initial outbreak contaminated vaccines were released by Baxter +++
by Harald Kautz-Vella
Passengers already dead at takeoff
The picture alternative media are drawing from the MH17 incident is getting more and more bizarre. According to first hand information of Ukrainians that got to the sight first, the plane was loaded with corps that were drained from blood and that obviously were already dead for quite some time. Many of them were completely striped from their cloth. In between the corps people found countless packets of blood serum. These statements are covered by the pictures published, that show naked bodies with heavy lesions but no blood at all. Later, when it became public the corps were already smelling, the media added some news about a failing cooling system on the train that was supposed to transport the corps west.
The fact that the plane apparently came down in one piece while the corps are told to be spread over an area of several kilometers hint to the possibility that the corps were deposited in the cargo area – and that the entire cargo was blown out by explosives that were deposited within the plane. Also, experts say the damage at the plane hints to an explosion directed outwards.
So who shot 777 – if anyone did
While the western media repeatedly “hint to the suspicion” that the plane was shot down by the rebels, the NSA-run “alternative media” in Russia state it was an Ukrainian attack that should have hit the plane of Vladimir Putin – that was crossing the same area half an hour later. This hints to a western strategy that is aiming to escalate the conflict on both sides, which meets the rhetoric’s of the officials. This impression is covered by a fully unqualified discussion run by the official experts published by the western state and corporate controlled media that can only be read as the attempt to not answer questions as long as possible.
One might start looking at the BUK-rocket systems that are said to be responsible for the shot. These systems are radar controlled, and the explosion is triggered when it is at 50 m distance from the plane spreading a cloud of shrapnel. So there is no chance to open the stomach of a plane of the size of a 777 with a buk rocket. Normally a number of batteries is guided from one radar station. To conquer a battery from the Ukrainian military (initial official version in western media) is as useless as getting a battery delivered by the Russians (secondary official version in western media), as long as there is no radar system at hand to guide the rockets fired. Apart from the fact, that it needs a few years of training and an elaborated electronic infrastructure to operate such a battery-radar unit.
It is a rather simple truth, that if one wants to find out who guided a rocket to its target one needs to look for the radar activity. This has been done and published by the Russians with straight-forward results: there was increased BUK-battery-presence AND radar activity on the Ukrainian side. Additionally, there was an Ukrainian jet close to MH17 minutes before it was shut down. Just as a reminder: the Maidan revolution was financed by the US Embassy, and guided by Gladio troops (NATO-inteligence).
Strongest hints to a western covert action, is the fact that all evidence and large part of the story “made up” was pre-arranged to the incident. The conversation of rebels stating that they shot down a plane was cut together from conversation-fragments und uploaded a day prior to the incident. Most ridiculous thing, that everyone who calls this a conspiracy theory might check out himself is, that even the names of the victims are obviously fake. The list is public. If one goes to the facebook-profiles of these people one finds out that all the profiles were created at the same day prior to the event. And all of them are empty. And there are no crying relatives around.
Why the Spanish?
Yoichi Shimatsu is a science writer, who organized public health seminars during the SARS and avian influenza outbreaks in Hong Kong and Bangkok. He was the lead investigative journalist in the 1995 Tokyo subway gassing and subsequent terrorist threats against Japan’s nuclear reactors. In an article published on the 19th of July he states:
Blood-drained corpses are the stuff of horror movies, but this nightmare arose from one of the busiest airports of “civilized” Europe, and one controlled by ITCS, a security company linked from its inception to the Israeli Mossad. Mad Scientists with renewed support from above . A reason for concern, early in this investigation, is the fact that The Netherlands, the origin of Flight 17, is the center for the engineering of weaponized viruses under Ron Fouchier, the closest research associate of the notorious Japanese influenza expert Yoshihiro Kawaoka. The flu-research center at Eramus Medical University in Rotterdam is the sister-laboratory of Kawaoka’s Institute of Infectious Virus Research at the University of Wisconsin, Madison. The deadly duo’s pseudo-scientific research includes the “perfection” of a Spanish flu virus that killed of 20 million victims worldwide in 1918-19. Kawaoka recently boasted that nothing can stop his newest variant of H5N1, the avian influenza virus. Fouchier’s fanatic disciples, meanwhile, have been weaponizing the H7N9 bird-flu virus that killed more than 40 people in China. (Weaponization involves three objectives, first, to hasten the ability of a virus to spread, that is, to be more contagious; second, to increase its lethality; and third, to develop an antidote available only to the chosen few.) Kawaoka and Fouchier are not mad scientists working on the fringe, they are accredited researchers with powerful funding support. Two years ago, the twin labs received a massive boost in funding from unidentified sources funneled through department budgets despite vociferous objections from other scientists as to the unstoppable risks. The patrons of the deadly research includes the chairman of the Eramus University trustee board, Anton Van Rossum, a former executive with Solvay, the Belgium chemical producer that illegally provided sarin-gas components to the Israeli biowarfare program aboard an El Al jetliner that crashed in Amsterdam. The El Al flight hit a crowded apartment block, soon after takeoff from Schiphol Airport, which also is the takeoff point for MH17. Aboard that El Al flight was a shipment of an RNA-based bioweapon known as mycoplasm, which replicates in water (for example, inside the human lungs) and is suspected to have been used in the two Gulf Wars against Iraq. Bioweapons, Solvay, Israeli, Schiphol, ICTS and Boeing are the common denominators between 1992 El Al crash and the 2014 Malaysia Airlines disaster.
So far to the real world evidence.
The idea that this could be the Spanish flu was confirmed by a number of clairvoyant sources as well as by radionics of the pictures of the corps published. Taking the information from pictures is a standard diagnosis system in informational medicine and tends to be highly reliable.
“V” was talking about this week delay between the incident and the moment the world will realize what happened. It is very likely that this statement refers to the incubation period of this deadly virus. Hours after this became obvious a network of doctors, natural healers and scientists NOT connected to the pharmaceutical industry started to network and to gather the knowledge necessary to face an outbreak of a weaponized Spanish flue.
The Spanish flue kills due to a co-infection with bacteria. The virus attacks the lungs, and opens the tissue to a number of bacteria. Due to the damage done by the bacteria, the lungs are filling with blood and liquid and the patient might die within less then a day. Also, the disease is known to affect people in their best age, while children and elder people stay healthy. This is due to the increased immune system of people in their 20s and 30s. It triggers a self-energizing regulatory circuit that is leading to an increased viral activity.
The development of the new medication was accomplished on Wednesday, the 23rd. It led to a combination of two remedies. A liquid, called “Spanish flue environment transformer” to be used as a cold spray (emergency) or from an hot vaporizer, that changes the environment within the lung by introducing both chemical and informational patterns of fungi as well as of a balanced bacteria-environment as well as colloidal gold. Viruses are known not to prosper in the presence of fungi. Pathological bacteria do not prosper in the presence of balanced bacteriological environments. Gold nano-particles are known do rip DNA. The increased activity of the immune system of people in their best years also could be modulated to a less risky state. This first remedy is not about healing. It is about winning time. The second remedy, “Spanish flue redox” contains an highly potent form of amorphous SiO2 as well as activated zeolite, two of the most potent anti-oxidants known, both have been – as single agents – already positively tested in conventional peer-review medical research for being helpful with viral infects.
The combination will hopefully reduce causalities – now of cause it is still impossible to say by how many percent, this will be shown by future experience.
Original forecast of an 777 incident over Europe from the 15th of July
Original posting by Yoichi Shimatso
Ukraine Spanish flue incident from 2009: